The Myeloma Infoline and Ask The Nurse services are fully staffed and are here to answer your questions and concerns and be a listening ear.

You can also visit our dedicated COVID-19 Information Hub for the latest information.

page

For Researchers

Myeloma UK funds research to find answers and lead change in our goal to Make Myeloma History.

Geographic Inequalities in Myeloma

Myeloma UK is inviting applications to answer questions about geographic inequalities in myeloma. We will award up to £100K to one research project to review the current landscape and produce an evidence base to help Myeloma UK improve outcomes for patients.

Research Objectives

The research project will provide evidence and increase understanding of the services myeloma patients and their family members have access to across the UK and how this impacts patient outcomes.

The objectives of this research call are to:

  • Understand what services myeloma patients and their families have access to at the local and regional levels across the UK.
  • Understand how local service access impacts myeloma patient outcomes including patient quality of life.

Call details and how to apply

Date call opens: Monday 1st June 2020

Deadline date: 3pm – Thursday 24th September 2020

Maximum funding limit: £100K

Maximum project duration:18 Months

Eligibility: The Principal Investigator must hold a permanent post at either a UK Higher Education Institute or the NHS.

Before you begin your application please ensure that you read the Call details and Guidance for applicants which can be found under supporting documents below. To apply please complete the Health Services Research Grant application form which can also be found under supporting documents below.

Completed applications should be emailed to research@myeloma.org.uk by the deadline. Applications received after the deadline will not be considered.If you have any questions about this call or eligibility, please contact us by emailing research@myeloma.org.uk

Peer review

Myeloma UK is an Association of Medical Research Charities (AMRC) member charity and adheres to the principle of peer review as set out by the AMRC. All competitive research applications received by the deadline will be peer reviewed in accordance with the Myeloma UK Peer Review Policy.

Acknowledgement of Support

Takeda UK Ltd. and Sanofi UK have funded the Myeloma Geographical Equalities Audit but have had no editorial control over the content/outputs. Takeda UK Ltd. has also supported the Myeloma Geographical Equalities Audit as an active member of the strategic advisory group.

Supporting documents

Research Policy Documents

More about the Myeloma UK research programme

You can see our Research Strategy. Applications to our research programme are Peer Reviewed in line with our Conflict of Interest policy and discussed by the Research Advisory Group. We support Open Access Publication to disseminate results to a broad audience.

Myeloma UK is member charity of AMRC, please read our statement on animal use in research.